Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy.
about
Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survivalTP53 status and response to treatment in breast cancersDistinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term SurvivalExploring molecular pathways of triple-negative breast cancerPrognostic Significance of Transverse Relaxation Rate (R2*) in Blood Oxygenation Level-Dependent Magnetic Resonance Imaging in Patients with Invasive Breast Cancer.Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer managementSubtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indicationsImmunomodulatory effects of anti-estrogenic drugs.Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma.Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information.Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to St Gallen consensus and intrinsic subtypes.A single nucleotide polymorphism in PIK3CA gene is inversely associated with P53 protein expression in breast cancer.IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma
P2860
Q34449010-B57D5643-4756-4C0D-B8D8-42A5552E4E03Q35043933-71995D70-1B27-4F37-A05D-D802B8C323DDQ35737504-A6F1C4B9-0DFC-4710-9953-FD34599C6DB8Q35959745-A3F99304-E233-49F1-983B-174D2798BB44Q36069162-E8033E43-D1A6-4383-989C-10EDB248D061Q36441485-2F86F3DA-3C24-4BB3-8A53-2BF4BB530F5EQ37607746-FD62ECE9-8A08-416A-99BD-3959B5079AD7Q38023107-F9037371-EF44-4240-B69F-3B7EF09E0172Q39094258-F2A25931-A63C-4307-9596-142073C34577Q41593112-E57135AA-235A-4F6B-B8D3-603096B1488EQ43591191-8AB0D46C-6EAB-475F-A244-4CBE4FDE6650Q53437314-99DE5417-D468-4676-9BE2-573C8E6524CBQ54346442-17CD0330-415F-4518-B9ED-0655B11EA0E4Q55247109-72739A5D-360C-4045-9978-69CFC0FB5080Q58719354-C6EB18A3-8FCB-4359-90B3-AD13E7EEE2B4
P2860
Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Overexpression of p53 is corre ...... tamoxifen after chemotherapy.
@en
Overexpression of p53 is corre ...... tamoxifen after chemotherapy.
@nl
type
label
Overexpression of p53 is corre ...... tamoxifen after chemotherapy.
@en
Overexpression of p53 is corre ...... tamoxifen after chemotherapy.
@nl
prefLabel
Overexpression of p53 is corre ...... tamoxifen after chemotherapy.
@en
Overexpression of p53 is corre ...... tamoxifen after chemotherapy.
@nl
P2093
P1476
Overexpression of p53 is corre ...... tamoxifen after chemotherapy.
@en
P2093
Cha Kyong Yom
Hee Jeong Kim
Hee Sung Kim
Jin Hee Sohn
Jong Won Lee
Jun Ho Kim
Sei Hyun Ahn
Yong Lai Park
P2888
P304
P356
10.1007/S10549-009-0560-5
P407
P577
2009-10-06T00:00:00Z
P5875
P6179
1006077431